Form 8-K - Current report:
SEC Accession No. 0001297184-25-000040
Filing Date
2025-07-21
Accepted
2025-07-21 16:14:21
Documents
12
Period of Report
2025-07-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K amph-20250718x8k.htm   iXBRL 8-K 51409
  Complete submission text file 0001297184-25-000040.txt   162511

Data Files

Seq Description Document Type Size
2 EX-101.SCH amph-20250718.xsd EX-101.SCH 3690
3 EX-101.LAB amph-20250718_lab.xml EX-101.LAB 15361
4 EX-101.PRE amph-20250718_pre.xml EX-101.PRE 10385
14 EXTRACTED XBRL INSTANCE DOCUMENT amph-20250718x8k_htm.xml XML 4681
Mailing Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730
Business Address 11570 SIXTH STREET RANCHO CUCAMONGA CA 91730 909-980-9484
Amphastar Pharmaceuticals, Inc. (Filer) CIK: 0001297184 (see all company filings)

EIN.: 330702205 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36509 | Film No.: 251137434
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)